Pfizer and BioNTech have signed an agreement with the Government of Canada to supply their Coronavirus vaccine based on BNT162 mRNA, subject to approval from Health Canada. The financial details of the agreement were not disclosed, but the terms were based on delivery dates and dose volumes. Vaccine is scheduled to be shipped during 2021.